IO Biotech
IO Biotech is a clinical stage biotech company developing disruptive immune therapies for the treatment of cancer. The pipeline of first-in-class immune modulating anti-cancer therapies is developed by a unique technology platform, T-win®, enabling the activation of T cells that are specific for immune-suppressive molecules. IO Biotech has a proven track record of progressing preclinical and clinical compounds. The two lead compounds targeting IDO and PD-L1 are in clinical development and several pipeline compounds are in pre-clinical phase.
Tech Stack (26 technologies)
Frequently Asked Questions
What technologies does IO Biotech use?+
IO Biotech uses 26 technologies including Contact Form 7, Modernizr, MonsterInsights.
What industry is IO Biotech in?+
IO Biotech operates in the Biotechnology industry.
Where is IO Biotech based?+
IO Biotech is headquartered in Germany.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026